Cited by 951Schizophrenia research and treatmentCardiac Health and Mental HealthDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 150 of the 152 references it cites were found in a registry or an index.

Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)

De Hert, M., Dekker, J.M., Wood, D., Kahl, K.G., Holt, R.I.G., Möller, H.-J.·2009·European Psychiatry

DOI 10.1016/j.eurpsy.2009.01.005

Open this paper in CoChat — free account

Abstract

People with severe mental illnesses, such as schizophrenia, depression or bipolar disorder, have worse physical health and reduced life expectancy compared to the general population. The excess cardiovascular mortality associated with schizophrenia and bipolar disorder is attributed in part to an increased risk of the modifiable coronary heart disease risk factors; obesity, smoking, diabetes, hypertension and dyslipidaemia. Antipsychotic medication and possibly other psychotropic medication like antidepressants can induce weight gain or worsen other metabolic cardiovascular risk factors. Patients may have limited access to general healthcare with less opportunity for cardiovascular risk screening and prevention than would be expected in a non-psychiatric population. The European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC) published this statement with the aim of improving the care of patients suffering from severe mental illness. The intention is to initiate cooperation and shared care between the different healthcare professionals and to increase the awareness of psychiatrists and primary care physicians caring for patients with severe mental illness to screen and treat cardiovascular risk factors and diabetes.

Integrity signals

Registry

Crossref · 10.1016/j.eurpsy.2009.01.005

Cites

150 of 150 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

RETRACTED: Obesity and physical activity: A review
Bensimhon, D., Kraus, W. E., & Donahue, M. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.03.005 · Cited by 122
Retracted
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1×
“- Document téléchargé le 23/06/2011 par AS OF EUROPEAN diabetes [78,131].”
Background
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
2007 Guidelines for the Management of Arterial Hypertension
Mancia, G., Backer, G. D., Dominiczak, A. F., Cífková, R., Fagard, R. H., Germanò, G., Grassi, G. M., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3281fc975a · Cited by 5,870
European guidelines on cardiovascular disease prevention in clinical practice: executive summary
Graham, I., Atar, D., Borch‐Johnsen, K., Boysen, G., Burell, G. K., Cífková, R., Dallongeville, J., Backer, G. D., Ebrahim, S. B. J., Gjelsvik, B., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm316 · Cited by 3,865
Self-citation
The Cardiovascular Health Study: design and rationale.
Fried, L. P., Borhani, N. O., Enright, P., Furberg, C. D., Gardin, J. M., Kronmal, R. A., Kuller, L. H., Manolio, T. A., Mittelmark, M. B., Newman, A., et al. (1991) · Annals of Epidemiology · doi:10.1016/1047-2797(91)90005-w · Cited by 3,652
Diagnosis and Classification of diabetes mellitus
Rossi, G. (2014) · Diapedia.org eBooks · doi:10.14496/dia..20 · Cited by 3,212
International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes
The International Expert Committee (2009) · Diabetes Care · doi:10.2337/dc09-9033 · Cited by 3,185
Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy.
Rozanski, A., Blumenthal, J. A., & Kaplan, J. (1999) · Circulation · doi:10.1161/01.cir.99.16.2192 · Cited by 2,846

Flagged first, then by citations

Show all 152 references

2 of the 152 references couldn’t be matched to a known paper.

Research works printed but not linked: 8

10.1176/ajp.2006.163.4.611 · DOI
Scheen, 2008, Traitement neuroleptique et troubles metabolic, Med Mal Metabol, 2, 593
Correll, 2008, Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents, J Clin Psychiatry, 69, 26
Citrome, 2007, Risk-Benefit Analysis of Available Treatments for Schizophrenia, Psychiatric Times, 1, 27
2008, Clinical Practice Guidelines for the prevention and management of diabetes in Canada, Can J Diabetes, 32, S1
Casey, 2004, Antipsychotic-Induced Weight Gain and Metabolic Abnormalities: Implications for Increased Mortality in Patients With Schizophrenia, J Clin Psychiatry, 65, 4
Henderson, 2005, Schizophrenia and comorbid metabolic disorders, J Clin Psychiatry, 66, 11
Nicol, 2009, Preliminary results of the MEAC study: metabolic effects of antipsychotics in children, Schizophr Bull, 35, 32

Sorted by citations

Items 501–600 of 948

Selective serotonin reuptake inhibitors and risk reduction for cardiovascular disease in patients with schizophrenia: A controversial but promising approach
Bellon, A., & Nguyen, K. (2021) · World Journal of Psychiatry · doi:10.5498/wjp.v11.i7.316 · Cited by 8
High prevalence of metabolic diseases, liver steatosis and fibrosis among Chinese psychiatric patients
Li, H., Chen, C., Chen, Y., Han, B., Chen, Y., Cheng, J., Wang, N., Wang, B., & Lu, Y. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-04684-1 · Cited by 9
Psychische und neurokognitive Erkrankungen und Diabetes mellitus (Update 2023)
Abrahamian, H., Kautzky‐Willer, A., Rießland-Seifert, A., Lebherz-Eichinger, D., Fasching, P., Ebenbichler, C. F., Kautzky, A., & Toplak, H. (2023) · Wiener klinische Wochenschrift · doi:10.1007/s00508-022-02117-9 · Cited by 8
Cardiovascular risk assessment methods yield unequal risk predictions: a large cross-sectional study in psychiatric secondary care outpatients
Quadackers, D. M. C., Liemburg, E. J., Bos, F. M., Doornbos, B., Risselada, A., PHAMOUS investigators, Bartels‐Velthuis, A. A., Bruggeman, R., Castelein, S., Jörg, F., et al. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-05022-1 · Cited by 8
Depression und Diabetes mellitus Typ 2
Deuschle, M., & Schweiger, U. (2012) · Der Nervenarzt · doi:10.1007/s00115-012-3656-9 · Cited by 8
Psychopharmaka und Diabetes
Ress, C., Tschoner, A., Kaser, S., & Ebenbichler, C. F. (2011) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-011-0004-9 · Cited by 8
The metabolic syndrome and schizophrenia: A comorbidity or an association?
Khalil, R. B. (2013) · Europe PMC (PubMed Central) · Cited by 8
Double disparities in the health care for people with schizophrenia of an ethnic-national minority
Gal, G., Munitz, H., & Levav, I. (2017) · Israel Journal of Health Policy Research · doi:10.1186/s13584-017-0166-z · Cited by 8
Voluntary physical activity protects against olanzapine-induced hyperglycemia
Shamshoum, H., McKie, G. L., Medak, K. D., Ashworth, K. E., Kemp, B. E., & Wright, D. C. (2020) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00876.2020 · Cited by 8
Training practice nurses to care for people with severe mental illness
Hardy, S., & Huber, J. (2014) · Primary Health Care · doi:10.7748/phc2014.03.24.3.18.e851 · Cited by 8
Discovering HIV related information by means of association rules and machine learning
Araujo, L., Martínez-Romo, J., Bisbal, O., Sánchez-de-Madariaga, R., The Cohort of the National AIDS Network (CoRIS), Portilla, J., Portilla, I., Merino, E., García, G., Agea, I., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-22695-y · Cited by 7
Schizophrenia treatment preferences of psychiatrists versus guidelines: A European perspective
Kuzman, M. R., Nordentoft, M., Raballo, A., Mohr, P., Fiorillo, A., Dom, G., Mihajlović, G., Jendričko, T., Chumakov, E. M., Bajraktarov, S., et al. (2025) · European Psychiatry · doi:10.1192/j.eurpsy.2025.10072 · Cited by 7
Antipsychotic‐induced weight gain: Is the weight over? New guidelines needed
de Boer, N., & Cahn, W. (2022) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13485 · Cited by 6
Prevalence of the metabolic syndrome and associated factors among inpatients with severe mental illness in Botswana: a cross-sectional study
Tsima, B. M., Opondo, P. R., Mosepele, M., Mautle, E., Bilker, W. B., & Gross, R. (2022) · BMC Cardiovascular Disorders · doi:10.1186/s12872-022-02939-5 · Cited by 7
Dietary interventions to improve metabolic health in schizophrenia: A systematic literature review of systematic reviews
Morris, A., Reed, T., McBride, G., & Chen, J. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.06.056 · Cited by 7
Metabolic syndrome rates in older patients with severe mental illness after five years of follow‐up and the association with mortality
de Louw, E. J., Paans, N. P. G., Sonnenberg, C., Konz, H., Meesters, P. D., van Grootheest, D., Oudega, M. L., Rhebergen, D., Kerssens, C. J., Comijs, H. C., et al. (2018) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5025 · Cited by 8
Can Sprint Interval Training (SIT) Improve the Psychological and Physiological Health of Adolescents with SMI?
Fox‐Harding, C., Sanders, R. H., Hoon, M. W., Starling, J., & Cobley, S. P. (2019) · Evidence-Based Practice in Child and Adolescent Mental Health · doi:10.1080/23794925.2019.1586497 · Cited by 7
The metabolic effects of antipsychotics in the early stage of treatment in first-episode patients with schizophrenia: A real-world study in a naturalistic setting
Cao, H., Meng, Y., Li, X., Ma, X., Deng, W., Guo, W., & Li, T. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.07.038 · Cited by 7
Minding metabolism: targeted interventions to improve cardio-metabolic monitoring across early and chronic psychosis
Kelly, J. R., Gounden, P., McLoughlin, A., Legris, Z., O’Carroll, T., McCafferty, R., Marques, L., Haran, M., Farrelly, R., Loughrey, K., et al. (2021) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-021-02576-5 · Cited by 8
Examining the feasibility, acceptability, validity and reliability of physical activity, sedentary behaviour and sleep measures in people with schizophrenia
Berry, A., Drake, R., Butcher, I., & Yung, A. R. (2021) · Mental health and physical activity · doi:10.1016/j.mhpa.2021.100415 · Cited by 9
Metabolic syndrome and 10-year risk of cardiovascular events among schizophrenia inpatients treated with antipsychotics
Feli, S. N., Ardekani, S. M. Y., Fallahzadeh, H., & Dehghani, A. (2019) · Medical Journal of the Islamic Republic of Iran · doi:10.47176/mjiri.33.97 · Cited by 7
Thermoneutral housing and preexisting obesity do not abolish the sexually dimorphic effects of olanzapine on weight gain in mice
Seguin, I., Medak, K. D., Shamshoum, H., Hahn, M., & Wright, D. C. (2023) · Obesity · doi:10.1002/oby.23630 · Cited by 7
Cardiorespiratory fitness and cardiovascular risk among in-patients with depression compared to healthy controls
Gerber, M., Cody, R., Beck, J., Brand, S., Donath, L., Eckert, A., Hatzinger, M., Imboden, C., Kreppke, J.-N., Lang, U. E., et al. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1193004 · Cited by 8
Metabolic Effects of Antidepressants: Results of a Randomized Study’s Interim Analysis
Santi, N. S., Biswal, S. B., Naik, B. N., Sahoo, J. P., & Rath, B. (2023) · Cureus · doi:10.7759/cureus.42585 · Cited by 7
Implementing a Mental Health and Primary Care Partnership Program in Placer County, California
Nover, C. H. (2014) · Social Work in Health Care · doi:10.1080/00981389.2013.864378 · Cited by 7
Cardiovascular Mortality and Related Risk Factors among Persons with Schizophrenia: A Review of the Published Literature
Fleischman, A., & Lurie, I. (2012) · Public health reviews · doi:10.1007/bf03391679 · Cited by 7
Impact of the Spanish Consensus on Physical Health of Patients with Schizophrenia
Sáiz-Ruiz, J., Sáiz-González, M. D., Alegría, A. A., Mena, E. M., Luque, J., & Bobes, J. (2010) · Revista de Psiquiatría y Salud Mental (English Edition) · doi:10.1016/s2173-5050(10)70021-2 · Cited by 7
Dysmetabolic features of the overweight patients receiving antipsychotic drugs: A comparison with normal weight and obese subjects
Manu, P., Correll, C. U., Wampers, M., van Winkel, R., Yu, W., Shiffeldrim, D., & Hert, M. A. F. D. (2013) · European Psychiatry · doi:10.1016/j.eurpsy.2012.12.001 · Cited by 7
Metabolic syndrome (MetS) in Lebanese patients with schizophrenia receiving atypical antipsychotic drugs
Khalil, R. B., Rohayem, J., said, N. A., Chammay, R. E., Haddad, R., & Richa, S. (2012) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2012.08.005 · Cited by 7
Psychometric properties of the Spanish version of the Body Weight, Image and Self-Esteem Evaluation questionnaire in patients with severe mental disorders
Al‐Halabí, S., García‐Portilla, M. P., Sáiz, P. A., Fonseca‐Pedrero, E., Bobes-Bascarán, T., Galván, G., García, C. I., Arrojo, M., Benabarre, A., Goikolea, J. M., et al. (2012) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2012.04.001 · Cited by 7
Motivational Interviewing and Psychiatry: Use in Addiction Treatment, Risky Drinking and Routine Practice
Cole, S., Bogenschutz, M. P., & Hungerford, D. (2011) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.9.1.foc42 · Cited by 7
Diabetes Resolution Following Discontinuation of a Second-Generation Antipsychotic
Strassnig, M., Awerbuck, J., & Ganguli, R. (2013) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/csrp.staw.01062013 · Cited by 7
Esquizofrenia y su asociación con enfermedades médicas crónicas
Orellana, G., Rodríguez, M., González, N., & Durán, E. (2017) · Revista médica de Chile · doi:10.4067/s0034-98872017000801047 · Cited by 9
Undiagnosed diabetes mellitus and associated factors among psychiatric patients receiving antipsychotic drugs at the University of Gondar Hospital, northwest Ethiopia
Asmelash, D., Getnet, W., Biadgo, B., Ambachew, S., Melak, T., Melese, L., Damite, S., Baynes, H. W., & Abebe, M. (2018) · Ethiopian Journal of Health Sciences · doi:10.4314/ejhs.v28i1.2 · Cited by 6
Cardiovascular events in hospitalised patients with schizophrenia: a survival analysis
Seddik, G. A., Hachem, D., Haddad, C., Hallit, S. R., Salameh, P., Nabout, R. A. E., & Zoghbi, M. (2019) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651501.2018.1545910 · Cited by 7
A systematic review of interventions aimed at improving the cardiovascular health of people diagnosed with personality disorders
Hall, K., Barnicot, K., Crawford, M., & Moran, P. (2019) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-019-01705-x · Cited by 10
Breast Cancer Stage and Treatment Among Ohio Medicaid Beneficiaries With and Without Mental Illness
Koroukian, S. M., Bakaki, P. M., Golchin, N., Tyler, C. V., Owusu, C., & Loue, S. (2015) · Journal of Oncology Practice · doi:10.1200/jop.2014.000034 · Cited by 7
Don’t just screen intervene; a quality improvement initiative to improve physical health screening of young people experiencing severe mental illness
Greenwood, P., & Shiers, D. (2016) · Mental Health Review Journal · doi:10.1108/mhrj-01-2015-0003 · Cited by 7
A novel digital intervention to facilitate diabetes self-management among people with schizophrenia and related disorders: development and acceptability testing of SMART
Arnautovska, U., Ritchie, G., Soole, R., Menon, A., Korman, N., Milton, A., Varnfield, M., Kelly, J., Jansen, P., Baker, A., et al. (2025) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s513272 · Cited by 7
“9 Self-management education is crucial for the prevention of secondary, short-and long-term micro-and macro-vascular complications associated with T2D.”
Twelve-month outcomes in overweight/obese users with mental disorders following a multi-element treatment including diet, physical activity, and positive thinking: the real-world "an apple a day" controlled trial
Giusti, L., Bianchini, V., Aggio, A., Mammarella, S., Salza, A., Necozione, S., Alunno, A., Ferri, C., Casacchia, M., & Roncone, R. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.903759 · Cited by 6
Implementing physician‐led medication reviews for patients with diabetes and severe mental disorder: A randomized controlled trial
Christensen, J. F. M. M., Düring, S. W., & Jűrgens, G. (2025) · British Journal of Clinical Pharmacology · doi:10.1002/bcp.70062 · Cited by 6
Assessment of mental and physical health outcomes over time in an integrated care setting
Bhatta, D., Sizer, M. A., Acharya, B., & Banjara, D. (2025) · BMC Family Practice · doi:10.1186/s12875-025-02876-0 · Cited by 11
Clinical Outcomes in Patients with Schizophrenia Treated with Long-Acting Injectable vs. Oral Antipsychotics: A Naturalistic Study
Bardi, F., Moccia, L., Kotzalidis, G. D., Boggio, G., Brugnami, A., Sfratta, G., Janiri, D., Sani, G., & Simonetti, A. (2025) · Healthcare · doi:10.3390/healthcare13141709 · Cited by 6
A smoking cessation intervention for people with severe mental illness treated in ambulatory mental health care (KISMET): study protocol of a randomised controlled trial
Küçükaksu, M. H., van Meijel, B., Jansen, L., Hoekstra, T., & Adriaanse, M. C. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-04599-x · Cited by 6
Serious Mental Illness is Associated with Elevated Risk of Hospital Readmission in Veterans with Heart Failure
Browne, J., Rudolph, J. L., Jiang, L., Bayer, T. A., Kunicki, Z. J., Vito, A. D. D., Bozzay, M. L., McGeary, J. E., Kelso, C. M., & Wu, W.-C. (2024) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2024.111604 · Cited by 6
Metabolic alterations associated with first and second generation antipsychotics: an twenty-years open study.
Franza, F., & Cervone, A. (2014) · PubMed · Cited by 6
Outcomes associated with different vaccines in individuals with bipolar disorder and impact on the current COVID-19 pandemic- a systematic review
Reininghaus, E. Z., Manchia, M., Dalkner, N., Bonkat, N., Squassina, A., Hodl, I., Vieta, E., Reif, A., Hájek, T., Landén, M., et al. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2021.09.001 · Cited by 6
Schizophrene Psychosen
Falkai, P., Schennach, R., Lincoln, T. M., Schaub, A., & Hasan, A. (2016) · Springer eBooks · doi:10.1007/978-3-642-45028-0_64-1 · Cited by 9
Domains of Vulnerability, Resilience, Health Habits, and Mental and Physical Health for Health Disparities Research
Wolfe, R. M., Beck-Felts, K., Speakar, B., & Spaulding, W. D. (2022) · Behavioral Sciences · doi:10.3390/bs12070240 · Cited by 5
Evaluation of health promotion programmes in severe mental illness: theory and practice
van Hasselt, F. M., Krabbe, P. F. M., Postma, M. J., & LOONEN, A. J. M. (2014) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1456 · Cited by 8
Stoffwechselstörungen unter antipsychotischer Therapie
Steffenhagen, N., Rummel‐Kluge, C., & Himmerich, H. (2011) · Der Nervenarzt · doi:10.1007/s00115-010-3207-1 · Cited by 6
The effect of ziprasidone on metabolic syndrome risk factors in subjects with schizophrenia: a 1 year, open-label, prospective study
Chue, P. S., Mandel, F. S., & Therrien, F. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.898139 · Cited by 6
A head-to-head comparison of sertindole and risperidone on metabolic parameters
Binder, M. D., Mittoux, A., He, Y., & Peuskens, J. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.07.030 · Cited by 6
Early environmental factors and somatic comorbidity in schizophrenia and nonschizophrenic psychoses: A 50-year follow-up of the Northern Finland Birth Cohort 1966
Korpela, H., Miettunen, J., Rautio, N., Isohanni, M. K., Järvelin, M., Jääskeläinen, E., AUVINEN, J. P., Keinanen-Kiukaanniemi, S. M., Nordström, T., & Seppälä, J. (2020) · European Psychiatry · doi:10.1192/j.eurpsy.2020.25 · Cited by 6
Risk of underdiagnosis of hypertension in schizophrenia patients
Sánchez, M. C., Escurriola, M. F., Bergé, D., Martin, M., Boreu, Q. F., & Goday, A. (2017) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2017.1346114 · Cited by 6
Evaluating Diabetes Care for Patients With Serious Mental Illness Using the Chronic Care Model
Vaez, K., Diegel-Vacek, L., Ryan, C. J., & Martyn-Nemeth, P. A. (2017) · Health Services Research and Managerial Epidemiology · doi:10.1177/2333392817734206 · Cited by 6
Early weight gain predicts later weight gain in depressed patients treated with antidepressants: Findings from the METADAP cohort
Asmar, K. E., Fève, B., Colle, R., Gressier, F., Vievard, A., Trabado, S., Verstuyft, C., Haffen, É., Polosan, M., Ferreri, F., et al. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.07.059 · Cited by 6
Medical Co-morbidities Among Patients with Severe Mental Illnesses in a Community Health Facility in Nigeria
Lasebikan, V. O., & Azegbeobor, J. (2016) · Community Mental Health Journal · doi:10.1007/s10597-016-0063-x · Cited by 5
Sex and gender differences in OCD: A scoping review and a two subtypes hypothesisPreprint
Zandt, M. A. V., Olfson, E., Stahnke, B., Taylor, S., Wise, A., Williams, C., Bloch, M. H., Pittenger, C., & Pushkarskaya, H. (2025) · medRxiv · doi:10.1101/2025.02.08.25321933 · Cited by 7
Exploring the effects of probiotics on olanzapine-induced metabolic syndrome through the gut microbiota
Syed, M., Chawla, K., Fayaz, S. M., Aranjani, J. M., Gayam, P. K. R., Mohandas Rao, K. G., Shenoy, P. A., Devi, V., Adiga, S., & Nayak, V. (2024) · Gut Pathogens · doi:10.1186/s13099-024-00664-2 · Cited by 5
Are Adults With Bipolar Disorder at Increased Cardiovascular Risk due to Their Physical, Biochemical, and Physiological Profiles? The FINEXT‐BD Study
Etxaniz‐Oses, J., Maldonado‐Martín, S., Zorrilla, E. P., Gorostegi-Anduaga, I., Apodaca‐Arrizabalaga, M. J., & González-Pinto, A. M. (2025) · Brain and Behavior · doi:10.1002/brb3.70297 · Cited by 5
Frequency of metabolic syndrome in psychiatric patients, is this the time to develop a standardized protocol to reduce the morbidity from an acute care psychiatry unit.
Munshi, T. A., Patel, A., Mazhar, M. N., Hassan, T., & Siddiqui, E. U. (2015) · PubMed · Cited by 5
The development of type 2 diabetes management in people with severe mental illness in the Capital Region of Denmark from 2001 to 2015
Bakkedal, C., Persson, F., Christensen, M., Kriegbaum, M., Mohr, G. H., Andersen, J. S., Lind, B., Lykkegaard, C., Siersma, V., & Rozing, M. P. (2024) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13650 · Cited by 5
Assessment of factors associated with antipsychotic-induced weight gain: A nationwide cohort study
Ishikawa, S., Hashimoto, N., Okubo, R., Sawagashira, R., Yamamura, R., Ito, Y. M., Sato, N., & Kusumi, I. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111231 · Cited by 5
Enhancing endogenous levels of GLP1 dampens acute olanzapine induced perturbations in lipid and glucose metabolism
Medak, K. D., Weber, A. J., Shamshoum, H., McKie, G. L., Hahn, M., & Wright, D. C. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1127634 · Cited by 5
Prospective association between depressive symptoms and blood-pressure related outcomes in Kosovo
Obas, K. A., Kwiatkowski, M., Bytyçi-Katanolli, A., Statovci, S., Jerliu, N., Ramadani, Q., Fota, N., Gerold, J., Zahorka, M., & Probst-Hensch, N. M. (2023) · PLOS Global Public Health · doi:10.1371/journal.pgph.0000851 · Cited by 10
Time trends in mortality for people with severe mental illness in Denmark 2000–2018
Lindstrӧm, C., Siersma, V., Kriegbaum, M., Willadsen, T. G., Bakkedal, C., Brodersen, J., Reventlow, S. D., Møller, A., & Rozing, M. P. (2024) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2024.2444262 · Cited by 5
Association of PCK1 with Body Mass Index and Other Metabolic Features in Patients With Psychotropic Treatments
Saigí-Morgui, N., Vandenberghe, F., Delacrétaz, A., Quteineh, L., Choong, E., Gholam‐Rezaee, M., Magistretti, P. J., Aubry, J., von Gunten, A., Preisig, M., et al. (2015) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000388 · Cited by 5
Peer support for schizophrenia
Chien, W. T., Lui, S., & Clifton, A. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010880 · Cited by 5
Niveau de vigilance des psychiatres pour les facteurs de risque cardiovasculaire chez les patients schizophrènes
Rouillon, F., Ganse, E. H. V., Vekhoff, P., Arnaud, R., Depret-Bixio, L., & Dillenschneider, A. (2015) · L Encéphale · doi:10.1016/j.encep.2014.12.003 · Cited by 5
Third sector facilitation of lived experience in research: a case study of service user and carer involvement in the PRIMROSE project
Gray, B., LARSEN, J. A., & Faulkner, A. (2013) · The Journal of Mental Health Training Education and Practice · doi:10.1108/jmhtep-03-2013-0008 · Cited by 5
Algorithms in psychiatry: state of the art.
Jašović‐Gašić, M., Dunjić-Kostić, B., Pantović-Stefanović, M., Cvetić, T., Marić, N. P., & Jovanović, A. (2013) · PubMed · Cited by 5
A Retrospective Chart Review of Screening on the Prevalence of Metabolic Syndrome (MetS) in an Irish Community Mental Health Service
Cocoman, A. M., & Gallagher, D. (2019) · Issues in Mental Health Nursing · doi:10.1080/01612840.2019.1609636 · Cited by 5
Where’s that stethoscope? A survey of psychiatrists’ attitudes to their role in managing physical health
Greenstone, H., & Burlingham, A. (2020) · The Journal of Mental Health Training Education and Practice · doi:10.1108/jmhtep-10-2019-0056 · Cited by 5
Incident atrial fibrillation and risk of psychoactive drug redemptions and psychiatric hospital contacts: a Danish Nationwide Register-based Follow-up Study
Hagengaard, L., Polcwiartek, C., Andersen, M. P., Sessa, M., Krogager, M. L., Gislason, G., Schou, M., Torp-Pedersen, C. T., Søgaard, P., & Kragholm, K. H. (2020) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcaa048 · Cited by 5
Study protocol of a randomized, double-blind, placebo-controlled, multi-center trial to treat antipsychotic-induced weight gain: the Metformin-Lifestyle in antipsychotic users (MELIA) trial
de Boer, N., Gülöksüz, S., van Baal, C. G. C. M., Willebrands, L., Deenik, J., Vinkers, C. H., Rossum, I. W.-V., Zinkstok, J., Wilting, I., Zantvoord, J. B., et al. (2021) · BMC Psychiatry · doi:10.1186/s12888-020-02992-4 · Cited by 5
The experiences of the caring dyad: (Un)articulated realities of living with cardiometabolic risk, metabolic syndrome and related diseases in severe mental illness
Sud, D., Maidment, I. D., Bradley, E., & Tritter, J. Q. (2021) · Health Expectations · doi:10.1111/hex.13322 · Cited by 4
Reducing cardiovascular risk factors in non-selected outpatients with schizophrenia
Hansen, M. V., Hjorth, P., Kristiansen, C. B., Vandborg, K., Gustafsson, L. N., & Munk‐Jørgensen, P. (2016) · International Journal of Social Psychiatry · doi:10.1177/0020764016629494 · Cited by 6
Long-term treatment of antipsychotics and combined therapy with other psychotropic medications inducing weight gain in patients with non-affective psychotic disorder: Evidence from GROUP, a longitudinal study
Burin, L. M., Hahn, M., da Rocha, N. S., van Amelsvoort, T., Bartels‐Velthuis, A. A., Bruggeman, R., de Haan, L., Schirmbeck, F. N., Simons, C. J. P., van Os, J., et al. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114680 · Cited by 5
Investigating Shared Genetic Bases between Psychiatric Disorders, Cardiometabolic and Sleep Traits Using K-Means Clustering and Local Genetic Correlation Analysis
Zammarchi, G., Conversano, C., & Pisanu, C. (2022) · Algorithms · doi:10.3390/a15110409 · Cited by 5
Gut Microbiome and its Role in the Development of Neurological Disorder (Schizophrenia)
Ameen, A., Akram, M. N., Farooq, S., Fatima, M., Raza, H., Naz, R., Aziz, U., Aziz, M., Tahir, S., & Hussain, A. (2023) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs2023175311 · Cited by 6
The interactive effects of type 2 diabetes mellitus and schizophrenia on all-cause mortality: The Fremantle Diabetes Study
Davis, W. A., STARKSTEIN, S. E., Bruce, D. G., & Davis, T. M. E. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.08.019 · Cited by 5
Cardiometabolic Risk and Monitoring in Psychiatric Disorders
Samaras, K. (2016) · Springer eBooks · doi:10.1007/978-3-319-32480-7_18 · Cited by 5
Incentivizing healthy lifestyle behaviors to reduce cardiovascular risk in people with serious mental illness: An equipoise randomized controlled trial of the wellness incentives program
Pratt, S. I., Brunette, M. F., Wolfe, R. S., Scherer, E. A., Xie, H., Bartels, S. J., Ferron, J. C., & Capuchino, K. (2019) · Contemporary Clinical Trials · doi:10.1016/j.cct.2019.04.005 · Cited by 7
Utilization of somatic healthcare in Croatian patients with schizophrenia spectrum disorder, major depression, PTSD and the general population
Jeleč, V., Bajić, Ž., Filipčić, I. Š., Pajić, I. P., Knežević, M. Š., Miloloža, I., Radić-Krišto, D., Benjak, T., Jakšić, N., Šagud, M., et al. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2190-8 · Cited by 4
Cardiovascular risk factor documentation and management in primary care electronic medical records among people with schizophrenia in Ontario, Canada: retrospective cohort study
O’Neill, B. G., Kalia, S., Aliarzadeh, B., Sullivan, F., Moineddin, R., Kelly, M. A., & Greiver, M. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-038013 · Cited by 5
Maladie cardiovasculaire et diabète chez les personnes atteintes d’une maladie mentale sévère
Scheen, A. J., Gillain, B., & Hert, M. D. (2010) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(10)70021-3 · Cited by 6
Anti-atherogenic properties of high-density lipoproteins in psychiatric patients before and after two months of atypical anti-psychotic therapy
Hussein, O., Izikson, L., Bathish, Y., Dabur, E., Hanna, A., & Zidan, J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115598320 · Cited by 5
Metabolic syndrome is negatively associated with cognition among endothelial nitric oxide synthase (eNOS)- 786C carriers in schizophrenia-spectrum disorders
Kraal, A. Z., Moll, A. C., Arvanitis, N. R., Ward, K. M., Dougherty, R. J., Grove, T. B., Burghardt, K. J., & Ellingrod, V. L. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.07.006 · Cited by 5
Metabolic Adverse Effects Associated with Antipsychotic Medications
Newcomer, J. W., & Leucht, S. (2010) · Wiley eBooks · doi:10.1002/9781444327298.ch28 · Cited by 5
Metabolic Syndrome and Mental Illness
Holt, R. I. G., & Peveler, R. (2011) · Wiley eBooks · doi:10.1002/9781444347319.ch11 · Cited by 5
Self-citation
A systematic review of randomized controlled trials in a general practice setting aiming to reduce excess all-cause mortality and enhance cardiovascular health in patients with severe mental illness
Langkilde, K., Nielsen, M. H., Damgaard, S. N., Møller, A., & Rozing, M. P. (2025) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2025.01.013 · Cited by 4
Effect of online aerobic exercise training in patients with bipolar depression: Protocol of a randomized clinical trial
Wang, X., Luo, H., Zhang, Y., Mao, M., Lu, Y., Zhang, Z., Jiang, C., & Luo, Q. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1011978 · Cited by 6
Characteristics of Comorbid Physical Disease in Patients With Severe Mental Illness in South Korea: A Nationwide Population-Based Study (2014-2019)
Na, E. J., Lee, J. S., Sohn, J. H., Yang, M., Park, Y., Sim, H.-B., & Lee, H. (2024) · Psychiatry Investigation · doi:10.30773/pi.2023.0224 · Cited by 5
Impact of institutional quality improvement initiatives on metabolic monitoring in mental disorder in patients treated with antipsychotics: A meta-analysis of intervention studies
Shin, S., Moon, S., Wang, J., & Choi, Y. J. (2024) · Journal of Global Health · doi:10.7189/jogh.14.04074 · Cited by 5
Physical health examination in outpatients with schizophrenia: the cost effectiveness of laboratory screening tests
Eskelinen, S., Suvisaari, J. V. J., & Suvisaari, J. (2020) · Annals of General Psychiatry · doi:10.1186/s12991-020-00321-3 · Cited by 4
Time trends of coronary procedures, guideline-based drugs and all-cause mortality following acute coronary syndrome in patients with bipolar disorder
Philipsen, L., Würtz, N., Polcwiartek, C., Kragholm, K. H., Torp-Pedersen, C. T., Nielsen, R. E., Jensen, S. E., & Attar, R. (2022) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2022.2102208 · Cited by 4
Risperidone upregulates the expression of adhesion molecules VCAM-I, and P-selectin in high-fat diet-induced obese mice
Akter, T., Islam, M. M., Begum, K., Begum, R., Roy, S., Ripon, M. A. R., Amin, M. T., & Hossain, M. S. (2023) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2023.100583 · Cited by 4
Reduction of arterial stiffness in depressive individuals responding to multimodal treatment
Schönthaler, E. M. D., Hamm, C., Reininghaus, B., Dalkner, N., & Reininghaus, E. Z. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.05.017 · Cited by 4
Cigarette smoking and risk of suicide in bipolar disorder: a systematic review
García-Jiménez, J., Gómez-Sierra, F. J., Martínez-Hortelano, A., Moreno-Merino, P., Serrano, B. G., Molero, P., & Gutiérrez-Rojas, L. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1179733 · Cited by 5

Authors: De Hert, M., Dekker, J. M., Wood, D., Kahl, K. G., Holt, R. I. G., & Möller, H.-J.
Affiliations: KU Leuven (BE)
Imperial College London (GB)
Medizinische Hochschule Hannover (DE)
University of Southampton (GB)
Ludwig-Maximilians-Universität München (DE)
ORCID: Wood, D.
Holt, R.I.G.
Venue: European Psychiatry
Publisher: Cambridge University Press (CUP)
Published: 2009-09
Volume: 24
Issue: 6
Pages: 412-424
ISSN: 0924-9338 (ISSN-L)
1778-3585
DOI: 10.1016/j.eurpsy.2009.01.005
OpenAlex: W2154493342
Cited by: 951
References: 152
Citations by year: 2026: 27 · 2025: 32 · 2024: 37 · 2023: 61 · 2022: 42 · 2021: 64 · 2020: 59 · 2019: 62 · 2018: 46 · 2017: 44 · 2016: 69 · 2015: 63 · 2014: 71 · 2013: 66 · 2012: 65
FWCI: 42.54
Type: journal article
Language: en
Open access: closed
Licence: www.cambridge.org/core/terms (unspecified, 3880 d)
Locations: European Psychiatry (publishedVersion)
PubMed (publishedVersion)
Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
Lirias (submittedVersion)
Pure Amsterdam UMC (submittedVersion)
Data Archiving and Networked Services (DANS) (submittedVersion)
Funders: Bristol-Myers Squibb
European Society of Cardiology
European Association for the Study of Diabetes
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: severe mental illness, cardiovascular disease, diabetes mellitus, schizophrenia, bipolar disorder, depression, cardiovascular risk factors, antipsychotic-induced weight gain, psychotropic drugs, cardiovascular risk screening, cardiovascular disease prevention, shared care, life expectancy, coronary artery disease
MeSH terms: Bipolar Disorder, Cardiovascular Diseases, Cause of Death, Cross-Sectional Studies, Major Depressive Disorder, Diabetes Mellitus, Follow-Up Studies, Humans, Mass Screening, Obesity, Psychotic Disorders, Psychotropic Drugs, Risk Factors, Schizophrenia, Societies, Medical, Comorbidity, Practice Guidelines as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks